![Rebecque Laba](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rebecque Laba
Corporate Officer/Principal bei Arcturus Therapeutics Ltd.
Aktive Positionen von Rebecque Laba
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Arcturus Therapeutics Ltd.
![]() Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 24.08.2018 | - |
Geschäftsführer | 01.08.2017 | 31.05.2018 | |
Finanzdirektor/CFO | 01.08.2017 | 24.08.2018 |
Karriereverlauf von Rebecque Laba
Ehemalige bekannte Positionen von Rebecque Laba
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Idun Pharmaceuticals, Inc.
![]() Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Verwaltungsdirektor | - | - |
Finanzdirektor/CFO | - | - | |
Celladon Corp.
![]() Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Verwaltungsdirektor | 01.11.2005 | - |
Finanzdirektor/CFO | 01.11.2005 | 06.06.2014 | |
Unternehmenssekretär | 01.10.2005 | - |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Director of Finance/CFO | 3 |
Chief Administrative Officer | 2 |
Corporate Secretary | 1 |
Sektoral
Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Celladon Corp.
![]() Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Health Technology |
Idun Pharmaceuticals, Inc.
![]() Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Health Technology |
Arcturus Therapeutics Ltd.
![]() Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Rebecque Laba
- Erfahrung